{
    "nctId": "NCT00551278",
    "briefTitle": "Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer",
    "officialTitle": "GeneSearch\u2122 Breast Lymph Node (BLN) Assay for Molecular Testing Protocol",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "The study will determine the sensitivity, specificity, negative predictive value and positive predictive value of the GeneSearch\u2122 BLN Assay by comparing its performance to permanent section Hematoxylin and Eosin (H&E) staining with IHC.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Previous diagnosis of carcinoma of the breast\n* Patient scheduled for sentinel lymph node dissection as per standard of care at the clinical site\n* 18 years or older\n* Female or male, and\n* Able and willing to give consent to participate in the study\n\nExclusion Criteria:\n\n* Patients taking part in other research studies that would interfere with their full participation in this study",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}